Related Experiment Video
Updated: Dec 11, 2025
07:13
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
4.7K
Approaches to Medication Management in Patients with Kidney Failure Opting for Conservative Management
Katherine H Cho1, Emily J Ashjian2, Michael Smith1
1Pharmacist, Michigan Medicine, Department of Pharmacy Services; and University of Michigan College of Pharmacy, Department of Clinical Pharmacy, Ann Arbor, MI.
Summary
Patients with kidney failure may opt for conservative management (CM-KF) without dialysis or transplant. This review details symptom management strategies and medication considerations for CM-KF, emphasizing individualized care.
Area of Science:
- Nephrology
- Geriatrics
- Palliative Care
Background:
- Conservative management of kidney failure (CM-KF) is an alternative to dialysis or transplantation.
- CM-KF focuses on pharmacologic symptom management, which presents challenges due to symptom complexity and potential adverse effects.
- Altered pharmacokinetics in kidney failure necessitate careful drug selection and monitoring.
Purpose of the Study:
- To review common symptoms experienced by patients with kidney failure under conservative management.
- To provide evidence-based recommendations for the pharmacologic management of these symptoms in CM-KF.
- To highlight safety considerations, including drug interactions and adverse effects, in CM-KF pharmacotherapy.
Main Methods:
- Systematic literature review of studies on conservative management of kidney failure.
- Analysis of pharmacologic interventions for common kidney failure symptoms.
- Evaluation of safety profiles and pharmacokinetic considerations for selected medications.
Main Results:
- Identified prevalent symptoms in kidney failure patients undergoing conservative management.
- Summarized effective pharmacologic strategies for symptom relief in CM-KF.
- Highlighted the importance of individualized medication selection based on patient factors and potential risks.
Conclusions:
- Pharmacologic management in CM-KF requires careful consideration of individual patient needs, comorbidities, and potential drug-related issues.
- Optimizing symptom control while minimizing harm is crucial in conservative kidney failure management.
- Further research is needed to specifically address the complexities of pharmacologic interventions in CM-KF.
Related Concept Videos
01:28Chronic Kidney Disease III: Interprofessional Care
245
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
245
01:20Acute Kidney Injury V: Interprofessional Care
177
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
177
01:18Chronic Kidney Disease IV: Nursing Management
197
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
197
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
115
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
115
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
184
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
184
01:22Acute Kidney Injury VI: Nursing Management
257
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
257